Locoregional control in patients with palpable medullary thyroid cancer: Results of standardized compartment-oriented surgery

被引:19
作者
de Groot, Jan Willem B.
Links, Thera P.
Sluiter, Willem J.
Wolffenbuttel, Bruce H. R.
Wiggers, Theo
Plukker, John Th. M. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Oncol, NL-9700 AB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 AB Groningen, Netherlands
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2007年 / 29卷 / 09期
关键词
medullary thyroid cancer; lymph node metastases; surgical management;
D O I
10.1002/hed.20609
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Extent of neck dissection is controversial in patients with palpable medullary thyroid cancer (MTC). Methods. We evaluated 64 MTC patients (19 hereditary, 45 sporadic) with palpable thyroid nodules (group 1, n = 35) or palpable lymph node metastases (group 2, In = 29). Standard surgery included total thyroidectomy, central compartment dissection, and additional neck dissection on indication. Results. In group 1, 40% of the patients were cured. Thirty-one percent of all patients had central, 23% ipsilateral, 14% contralateral, and 14% mediastinal, metastases. Fifty-one percent developed locoregional recurrence. Locoregional recurrence (p =.043) and reoperations (p =.020) were noted more often after a less than standard initial procedure, In group 2, no patients were cured, All had central, 93% ipsilateral, 45% contralateral, and 52% mediastinal metastases. Thirty-eight percent developed locoregional recurrence. Conclusions. Locoregional recurrence frequently occurs in palpable MTC, and tumor control may be improved by standard central, bilateral, and upper mediastinal neck dissection. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:857 / 863
页数:7
相关论文
共 26 条
  • [1] Medullary thyroid cancer: Analyses of survival and prognostic factors and the role of radiation therapy in local control
    Brierley, J
    Tsang, R
    Simpson, WJ
    Gospodarowicz, M
    Sutcliffe, S
    Panzarella, T
    [J]. THYROID, 1996, 6 (04) : 305 - 310
  • [2] Buhr H J, 1995, Eur J Surg Oncol, V21, P195, DOI 10.1016/S0748-7983(95)90534-0
  • [3] Medullary thyroid cancer
    Clayman, GL
    El-Baradie, TS
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) : 91 - +
  • [4] Lymph node dissection and medullary thyroid carcinoma
    Dralle, H
    [J]. BRITISH JOURNAL OF SURGERY, 2002, 89 (09) : 1073 - 1075
  • [5] COMPARTMENT-ORIENTED MICRODISSECTION OF REGIONAL LYMPH-NODES IN MEDULLARY-THYROID CARCINOMA
    DRALLE, H
    DAMM, I
    SCHEUMANN, GFW
    KOTZERKE, J
    KUPSCH, E
    GEERLINGS, H
    PICHLMAYR, R
    [J]. SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1994, 24 (02): : 112 - 121
  • [6] The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer
    Fersht, N
    Vini, L
    A'Hern, R
    Harmer, C
    [J]. THYROID, 2001, 11 (12) : 1161 - 1168
  • [7] Surgical strategy for the treatment of medullary thyroid carcinoma
    Fleming, JB
    Lee, JE
    Bouvet, M
    Schultz, PN
    Sherman, SI
    Sellin, RV
    Friend, KE
    Burgess, MA
    Cote, GJ
    Gagel, RF
    Evans, DB
    [J]. ANNALS OF SURGERY, 1999, 230 (05) : 697 - 707
  • [8] Extent of disease and practice patterns for medullary thyroid cancer
    Kebebew, E
    Greenspan, FS
    Clark, OH
    Woeber, KA
    Grunwell, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (06) : 890 - 896
  • [9] Medullary thyroid cancer.
    Kebebew E.
    Clark O.H.
    [J]. Current Treatment Options in Oncology, 2000, 1 (4) : 359 - 367
  • [10] Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer
    Kebebew, E
    Kikuchi, S
    Duh, QY
    Clark, OH
    [J]. ARCHIVES OF SURGERY, 2000, 135 (08) : 895 - 899